SGX:BSLHealthcare
Raffles Medical Group (SGX:BSL) Valuation Check After FY2025 Results And Proposed Final Dividend
Raffles Medical Group (SGX:BSL) has drawn fresh attention after releasing its full year 2025 results, together with a proposed final ordinary dividend of 3.0 Singapore cents per share, subject to shareholder approval in April.
See our latest analysis for Raffles Medical Group.
The earnings announcement and proposed S$0.03 dividend appear to have coincided with improving sentiment, with a 30 day share price return of 6.0% helping lift the 1 year total shareholder return to 17.4%, even though...